Grants and Contributions:
Title:
Immobilization and In Vivo Dosimetry
Agreement Number:
887031
Agreement Value:
$636,062.00
Agreement Date:
May 22, 2017 - Mar 29, 2019
Description:
3D Bolus wishes to solve the complex issues of producing customized immobilization devices for breast, head and neck and develop technology to incorporate 3D printable in vivo dosimeters to allow real-time measurement of patient dose and quality assurance.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Halifax, Nova Scotia, CA B3H 0A8
Reference Number:
172-2018-2019-Q1-887031
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
783348121
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 126 days. The total amended value is 205,878 dollars.
Amendment Date
Dec 19, 2018
Recipient's Legal Name:
Adaptiiv Medical Technologies Inc.
Federal Riding Name:
Halifax
Federal Riding Number:
12005
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110
Amendments: